SEC Form 3 · accession 0001214659-18-004588
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C. Robins
10% Owner
Period of report
Sep 15, 2017
Accepted (ET)
Jun 27, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 3,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
In December 2016 Tetralogic (the company) deregistered their common stock under sections of the Securities Exchange Act of 1934. In concurrence with legal review, previous and subsequent ownership reporting requirements under sections 16(a) and 13(d) are done so in good faith and voluntary basis. Reporting person is not and nor has been an affiliate of the company.